Jonathan Bye
Lawyers
Filters
Carvana $3.275 billion senior notes offering
The high-yield notes are due 2030
Carvana $1.25 billion follow-on offering
The shares are listed on the New York Stock Exchange
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Nurix Therapeutics $150 million at-the-market offering
We advised the sales agent on the stock offering
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering
Nurix Therapeutics $160.4 million follow-on offering
We advised the underwriters on the equity offering
Electronic Arts $1.5 billion senior notes offering
We advised the underwriters in connection with the global notes offering
Surgalign Holdings $37.5 million follow-on offering
We advised the underwriters on the equity offering
IDEAYA Biosciences $90 million at-the-market offering
We advised the sales agent on the SEC-registered equity offering